Global Therapeutic Respiratory Devices Market Set to Reach USD 80.2 Billion by 2033 Amid Rising Respiratory Disease Prevalence

The global therapeutic respiratory devices market is poised for significant growth, with a forecasted increase from USD 50.6 billion in 2023 to an impressive USD 80.2 billion by 2033. This remarkable expansion represents a Compound Annual Growth Rate (CAGR) of 4.7%, driven by the increasing prevalence of respiratory diseases worldwide.

Recent market analyses highlight the urgent need for innovative therapeutic solutions as respiratory ailments continue to rise. The growing incidence of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia underscores the critical demand for advanced healthcare technologies aimed at enhancing respiratory care outcomes.

Innovations in therapeutic devices—including ventilators, continuous positive airway pressure (CPAP) machines, and nebulizers—are central to this market growth. These devices are not only vital for patient treatment but also play a crucial role in improving the overall quality of life for individuals suffering from respiratory disorders.

As healthcare providers and patients alike seek effective solutions to manage respiratory health, the market for therapeutic respiratory devices is expected to see continued investment and innovation in the coming years. Industry leaders are committed to developing state-of-the-art technologies that respond to the evolving needs of patients and healthcare systems globally.

The surge in demand for advanced respiratory solutions stems from the increasing prevalence of chronic obstructive pulmonary disease (COPD), sleep apnea, and various other respiratory ailments. Factors contributing to this growth include:

  • Rising Prevalence of Respiratory Diseases: Chronic obstructive pulmonary disease (COPD) and sleep apnea are among the leading respiratory ailments propelling the demand for therapeutic devices.
  • Focus on Improved Healthcare Infrastructure: Governments and healthcare organizations globally are prioritizing enhanced healthcare infrastructure and accessibility to medical facilities, thereby escalating the need for these devices.
  • Increased Investment in Research and Development (R&D): The COVID-19 pandemic highlighted the pivotal role of respiratory support devices, prompting escalated investments in research and development for more sophisticated and efficacious solutions.

This growth trajectory underscores the significance of innovation and advancement in addressing the evolving healthcare landscape, particularly concerning respiratory health.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Key Takeaways:

  • Existence of modern healthcare facilities in the United States and Canada, the therapeutic respiratory devices market in North America gained over 36% market share in 2021.
  • The Asia Pacific is predicted to expand the quickest throughout the forecast period, owing to factors such as increased asthma incidence in adults and children, as well as technology improvements.
  • Additionally, the market expansion would be aided by rising healthcare awareness and improved healthcare infrastructure.
  • The clinical trial of Tempol for the treatment of COVID-19 by Adams Respiratory Therapeutics Inc has surpassed enrollment expectations.
  • COPD is estimated to affect 10% of adults aged 75 and older in the United States, according to the Journal of the Italian Society of Gerontology and Geriatrics.
  • According to statistics issued by the Global Initiative for Asthma (GINA), an estimated 100 million people with asthma are expected to be diagnosed by 2025.

Competitive Landscape:

  • Aerin Medical
  • BMC Medical Co., Ltd.
  • CareFusion Corporation
  • Covidien Plc
  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Hamilton Medical
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic
  • Nidek Medical Products, Inc.
  • Teleflex Incorporated
  • Smiths Medical

Acquisitions and mergers, the launch of new products and services, partnerships and joint ventures, MoU agreements, V.C. and funding activities, R&D activities, and geographic expansion, among other noteworthy activities by key players in the therapeutic respiratory devices market, are among the key strategic developments in the competitive landscape.

  • Acapella, a select blue vibratory PAP therapy device, was released by Smiths Medical in April 2021. It is a drug-free supplementary therapy for people with asthma, COPD, cystic fibrosis, and lung illness that aids in the evacuation of secretions.
  • Koninklijke Philips N.V. finalized the acquisition of BioTelemetry, Inc., a firm located in the United States, in February 2021. This aided in the expansion of Philips’ product line, resulting in increased sales of therapeutic respiratory devices.

Key Segments:

By Product:

  • Positive Airway Pressure (PAP) Devices
    • Continuous Positive Airway Pressure (CPAP) Devices
    • Auto-titrating Positive Airway Pressure (APAP) Devices
    • Bi-level Positive Airway Pressure (BiPAP) Devices
  • Oxygen Concentrator
    • Fixed Oxygen Concentrators
    • Portable Oxygen Concentrators
  • Ventilators
    • Adult Ventilators
    • Neonatal Ventilators
  • Inhalers
    • Metered Dose Inhaler (MDI)
    • Dry Powder Inhaler (DPI)
    • Soft Mist Inhaler (SMI)
  • Nebulizers
    • Compressor-based Nebulizers
    • Piston-based Hand-held Nebulizers
    • Ultrasonic Nebulizers
  • Humidifiers
    • Heated Humidifiers
    • Passover Humidifiers
    • Integrated Humidifiers
    • Built-in Humidifiers
    • Standalone Humidifiers
  • Others

By Application:

  • COPD
  • Obstructive Sleep Apnea
  • Asthma
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Others

By End-use:

  • Hospital
  • Homecare Settings
  • Emergency Centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Capnography Equipment Market Set for Substantial Growth, Projected to Reach USD 536.35 Million by 2032

The global capnography equipment market is on the brink of significant expansion, with projections indicating a robust Compound Annual Growth Rate (CAGR) of 4.4% over the forecast period. Anticipated to surpass USD 536.35 million by 2032, the market is poised to grow from USD 334 million in 2021, driven by several critical factors contributing to its upward trajectory.

A primary catalyst for this market growth is the increasing prevalence of respiratory disorders globally, which underscores the urgent need for continuous monitoring and advanced respiratory support solutions. Capnography equipment is highly valued for its essential role in monitoring carbon dioxide levels in exhaled breath, making it a crucial tool in patient care within critical and emergency settings.

As healthcare providers recognize the importance of precise monitoring to enhance patient outcomes, the demand for capnography equipment is expected to rise significantly. This growth reflects a commitment to improving respiratory care and ensuring patient safety across various medical environments.

Industry experts highlight that advancements in capnography technology, coupled with a growing awareness of its applications in anesthesia, emergency medicine, and critical care, will further drive market demand. As healthcare systems increasingly prioritize patient-centered care and evidence-based practices, capnography equipment will remain at the forefront of respiratory monitoring solutions.

Key factors supporting the growth of the capnography equipment market include:

  • Rise in Respiratory Diseases: With an alarming increase in respiratory ailments globally, the demand for effective monitoring and treatment options is escalating, driving the need for advanced capnography equipment.
  • Expansion of Healthcare Facilities: Emerging economies are witnessing a surge in the establishment of healthcare facilities, creating a larger market for medical equipment, including capnography devices.
  • Supportive Government Initiatives: Governments across various countries are actively supporting healthcare infrastructure development and initiatives to combat respiratory diseases, fostering a conducive environment for market growth.
  • Product Portfolio Diversification: Manufacturers are continuously diversifying their product portfolios, incorporating technological advancements and innovations to meet the evolving needs of healthcare professionals and patients.
  • Rise in Cardiac Surgeries: The increasing number of cardiac and cardiopulmonary surgeries worldwide necessitates advanced monitoring equipment like capnography devices, further fueling market growth.
  • Focus on Customer and Employee Experience: Emphasis on providing exceptional customer and employee experience is driving manufacturers to innovate, leading to improved product performance and user satisfaction.
  • Business Model Innovation: Companies are embracing innovative business models to enhance revenue, profitability, and market competitiveness, contributing to the overall growth of the capnography equipment market.

The demand for capnography equipment is expected to continue its upward trajectory, driven by extensive research and development efforts aimed at introducing technological advancements, particularly in the development of portable capnography monitors.

As the prevalence of respiratory diseases persists and government initiatives remain supportive, the capnography equipment market is poised for sustained growth in the foreseeable future.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Key Takeaways: “North America Takes the Demand for Capnography Equipment to New Highs by 2022 to 2032”

  • The demand for capnography equipment in North America is expected to reach new heights between 2022 and 2032.
  • This growth is likely driven by several factors, including an aging population, increasing awareness of respiratory diseases, and rising healthcare spending.
  • Capnography equipment is used to monitor carbon dioxide levels in exhaled breath, which can be a valuable tool for diagnosing and managing respiratory conditions.

Potential benefits of increased capnography equipment use:

  • Improved patient outcomes
  • Earlier diagnosis of respiratory conditions
  • More effective treatment of respiratory diseases

Areas for further research:

  • The long-term impact of capnography equipment use on healthcare costs
  • The effectiveness of capnography equipment in different clinical settings

Key Players of the Global Capnography Equipment Market:

Some of the key market players critical players in the capnography equipment market covered by the market analysis report are Koninklijke Philips N.V., Drägerwerk AG & Co. KGAA., Nihon Kohden Corporation, Zoll Medical (Asahi Kasei Corporation), Edan Instruments, Inc., Hamilton Medical, Masimo Corporation, Monday DS USA, Inc., Nonna Medical, Inc., Schiller, Smiths Medical, Advantech, and BPL Medical Technologies.

Some of the Recent Developments in the Capnography Equipment Market:

  • ZOLL Medical Corporation, a subsidiary of Asahi Kasei Company, acquired a medical device manufacturer in Israel named Itamar Medical Ltd. (Itamar Medical) in December 2021.
  • Masimo Corporation and Philips N.V. signed an agreement in May 2020 to integrate Masimo NomoLine Capnography and O3 Regional Oximetry in some selected Philips patient capnography monitors. Philips Corporation has also planned to integrate Masimo measurement technologies with IntelliVue MX-Series multi-parameter monitors that help assess patients’ cerebral oximetry and ventilation status.

Key Segments:

By Product Type:

  • Multiparameter Capnometers
    • Handheld Capnometers
    • Conventional Capnometers
  • Standalone Capnometers
  • Handheld Capnometers
  • Conventional Capnometers

By Technology:

  • Mainstream Capnometers
  • Sidestream Capnometers
  • Microstream Capnometers

By Application:

  • Cardiac Care
  • Trauma and Emergency Care
  • Respiratory Monitoring
  • Other Applications

By End User:

  • Hospitals
  • Ambulatory Surgery Centres
  • Home Care
  • Other End Users

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cell Culture Media Market Poised for Significant Growth, Projected to Reach USD 6,699.93 Million by 2034: Driving Innovation in Biopharmaceuticals and Research | Future Market Insights

The global cell culture media market is set to experience substantial growth, with an estimated size of approximately USD 3,513.8 million in 2024, reflecting a robust compound annual growth rate (CAGR) of 6.66% over the forecast period. By 2034, the market is projected to reach USD 6,699.93 million, driven by advancements in the biopharmaceutical industry and the increasing demand for innovative cell culture solutions.

In recent years, the biopharmaceutical sector has undergone significant technological advancements, necessitating effective and innovative cell culture media formulations that meet the evolving needs of advanced research and manufacturing processes. These specialized media play a crucial role in supporting cell growth, viability, and productivity, which are essential for developing cutting-edge therapeutic products.

Academic research institutes and biopharmaceutical companies are increasingly adopting advanced cell culture media solutions, which allow for precise control over the growth environment. This capability enables researchers to establish optimal conditions for cell cultivation, ensuring cell viability, reproducibility, and consistency, and ultimately leading to more reliable experimental results.

Additionally, the industrial-scale manufacturing of biological drugs and vaccines relies heavily on cell culture media, given their critical role in providing the essential nutrients and environment necessary for optimal cell growth and productivity. Furthermore, cancer research institutes utilize these media for experimental studies, focusing on cell behavior and testing potential anticancer compounds.

As the demand for biopharmaceutical products continues to rise, the cell culture media market is poised for unprecedented growth. The increasing emphasis on advanced research methodologies and the development of novel therapeutics further underscore the importance of these media in driving innovation within the industry.

“Companies must collaborate with research institutions, biotech companies, and other industry players. These alliances are expected to facilitate the exchange of knowledge, access to new technologies, and the development of joint research projects, contributing to advancements in cell culture media,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Key Takeaways from the Market Study:

  • The serum-free media segment dominates the cell culture media market with a share of 51.00%.
  • On the basis of application, the cancer research segment leads the cell culture media market with a share of 43.40%.
  • The cell culture media market in the United States is predicted to grow at a remarkable CAGR of 7.10% through 2034.
  • The cell culture media market in Germany is predicted to rise at a whopping 7.40% CAGR through 2034.
  • The cell culture media market in Japan has the potential to increase at 7.70% CAGR through 2034.
  • The Chinese cell culture media market is predicted to rise by 8.50% CAGR through 2034.
  • The cell culture media market in the United Kingdom is predicted to grow at a CAGR of 7.00% through 2034.

Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!

Competitive Landscape:

Key players in the global cell culture media market, such as Avantor, Inc., Thermo Fisher Scientific, Inc., and Lonza Group AG, demonstrate market dominance with established positions and significant contributions to the industry’s growth.

The landscape is marked by intense research and development activities, with companies investing heavily in innovation. This focus includes the development of serum-free and defined media, optimization of existing formulations, and the integration of advanced technologies to address the dynamic requirements of biopharmaceutical and life sciences research.

Key Companies in the Market:

  • Avantor, Inc.
  • Thermo Fisher Scientific, Inc.
  • Caisson Laboratories Inc.
  • Becton Dickinson and Company
  • Lonza Group AG
  • Bio-Rad Laboratories, Inc.
  • General Electric Company
  • Cell Culture Technologies LLC
  • Corning Incorporated
  • Fujifilm Holdings Corporation
  • Hi Media Laboratories Pvt. Ltd.
  • Merck & Co., Inc.

Market Segmentation:

By Type:

  • Serum-free Media
  • CHO Media
  • HEK 293 Media
  • BHK Media
  • VERO Cell Media
    • Insect Cell Media
    • Serum-free Stem Cell Media
    • CAR T-cell Media
    • Other Serum-free Media
    • Classical Media & Salts
    • Stem Cell Culture Media
    • Specialty Media
    • Chemically defined Media
    • Other Cell Culture Media

By Application:

  • Biopharmaceutical Production
  • Monoclonal antibodies
  • Cancer Research
  • Vaccines production
  • Other therapeutic proteins
  • Diagnostics
  • Drug Screening & Development
  • Tissue Engineering & Regenerative Medicine
  • Cell and gene therapy
  • Other tissue engineering & regenerative medicine applications
  • Other Application

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Antibody Therapy Market Set for Extraordinary Growth, Projected to Reach USD 824 Billion by 2033 Amid Advancements in Immunotherapy

The global antibody therapy market is on the brink of remarkable expansion, driven by rapid advancements in immunotherapy and a surge in demand for innovative treatments for critical conditions, including cancer and COVID-19. Recent market analysis reveals that the sector is anticipated to experience a robust Compound Annual Growth Rate (CAGR) of 13.4% from 2023 to 2033.

The market value is projected to escalate from USD 235 billion in 2023 to an astonishing USD 824 billion by 2033. This growth trajectory is fueled by continuous innovations in antibody therapies, which are increasingly recognized as pivotal in the battle against complex and life-threatening diseases.

As the prevalence of serious health conditions rises, the adoption of antibody therapies is accelerating, offering patients a more effective and less invasive alternative to traditional chemotherapy. Monoclonal antibody therapy, a form of passive immunotherapy, is becoming a preferred choice for individuals suffering from cancer and other immune-related diseases. This treatment enhances the immune system’s ability to fight disease by promoting the generation of new cells and fortifying the body’s natural defenses, resulting in improved patient outcomes with fewer side effects.

Global healthcare systems are increasingly acknowledging the transformative potential of antibody therapies. Significant advancements in cell therapy, particularly in oncology, are contributing to the swift growth of the antibody therapy market, as healthcare providers embrace these cutting-edge treatment options.

Furthermore, the market is witnessing a surge in research and development activities, leading to the introduction of novel cancer therapies and cell treatment techniques. The rising popularity of therapeutic antibody derivatives is enriching the market landscape, creating an encouraging environment for ongoing innovation and expansion.

The remarkable growth trajectory of the antibody therapy market underscores its critical role in revolutionizing disease management and treatment paradigms. With a steadfast commitment to innovation, stakeholders across the healthcare ecosystem are poised to unlock new avenues for enhancing patient outcomes and overall quality of life.

Key Points:

  • The United States market leads the space in terms of market share and CAGR. The market is expected to cross a value of USD 291.9 billion by 2033. The regional market is expected to thrive at a CAGR of 13.1% between 2023 and 2033.
  • The Chinese antibody therapy market is another significant Asian market. It thrives at a steady CAGR of 12.7% during the forecast period. The market is likely to reach a value of USD 59.1 billion by 2033. Asian economies like India and China are building their healthcare infrastructure by advancing them with the latest therapeutic solutions to high-risk diseases like cancer.
  • Monoclonal antibodies are likely to thrive in the antibody type category, as it provides immediate and short-term immunity from conditions like COVID-19. It is expected to thrive at a CAGR of 13.2% during the forecast period.
  • The hospital segment leads the end-user category with a CAGR of 12.6% between 2023 and 2033. The growth is attributed to the bigger budget, higher patient traffic, and easy availability of therapeutic experts.

Elevated Market Interest: Delve into In-Depth Trends and Insights with Our Full Report!

Competitive Landscape:

The key competitors create better packages with advanced cell-therapy solutions that deliver treatment with lesser side effects and higher effectiveness. Key competitors also merge, acquire, and partner with other companies to increase the supply chain and distribution channel. The key players in the market are: F. Hoffmann-La Roche Ltd., AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc.

For instance:

  • Amgen Inc. has introduced its monoclonal antibody that holds bioengineered molecules, specially designed to target protein involved in different types of diseases.
  • AbbVie Inc. has launched the first fully human monoclonal antibody, along with the antibody drug conjugates, that applies the target of an antibody that delivers a therapeutic agent. The company’s other research targets include interleukin-1, interleukin-23, and JAK (Janus Kinase Inhibitors)

Key Segments:

By Type:

  • Monoclonal Antibodies
    • Oncology, Autoimmune Disease
    • Infectious Disease
    • Other
  • Antibody Drug Conjugates

By End User:

  • Hospitals
  • Specialty Centers
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Flexible Endoscopes Market Set for Significant Growth, Projected to Reach USD 16.73 Billion by 2033

The global flexible endoscopes market is on the verge of substantial growth, with an anticipated Compound Annual Growth Rate (CAGR) of 6.4% through 2033. This remarkable surge is expected to elevate the market’s value to USD 16.73 billion by the end of 2033, rising from USD 8.98 billion in 2023.

Key factors driving this impressive expansion include the increasing demand for flexible endoscopes, particularly in gastrointestinal examinations. As global living standards continue to improve, there is a growing emphasis on healthcare, leading to increased investment in medical services and infrastructure worldwide.

“The global flexible endoscopes market is witnessing robust growth, fueled by advancements in healthcare technology and a heightened focus on diagnostic accuracy,” said an FMI. “As healthcare standards improve globally, there’s a parallel increase in the adoption of flexible endoscopic procedures, which offer minimally invasive solutions and enhance patient outcomes.”

Flexible endoscopes play a pivotal role in modern medicine, enabling physicians to conduct detailed examinations with minimal discomfort to patients. Their flexibility and precision make them indispensable tools across various medical specialties, further contributing to market growth.

Beyond gastrointestinal applications, flexible endoscopes are gaining traction in urology, gynecology, and otolaryngology, underscoring their versatility in clinical settings. This adaptability, combined with ongoing technological advancements, is expected to sustain the market’s upward trajectory in the coming years.

Key Takeaways:

  • In numerous chronic disease conditions, many medical professionals advise early-stage diagnosis, which is anticipated to augment the demand for flexible endoscopes with lightning speed. These devices allow invasive procedures to become easier for medical practitioners to perform accurate diagnoses and make treatment less painful for patients.
  • The requirement for flexible endoscopes is anticipated to increase as a result of hospitals and medical facilities investing heavily in the setup of flexible endoscope cameras using smartphone technology.
  • Veterinary flexible endoscopes have drastically become popular among veterinarians in the field of animal care as animal husbandry commercialization and pet ownership have increased, especially in developed nations.
  • The elevating demand for minimally invasive procedures has significantly increased over the past decade. Owing these procedures employed can effectively reduce the number and size of cuts or incisions performed on the body.
  • Endoscopies are known to be minimally invasive medical procedures that enter the body through openings. Endoscopies have therefore been widely utilized for diagnostic purposes around the world. This causes the need for flexible endoscopes to soar, which in turn fuels the expansion of the market under study offering lucrative opportunities to the market players.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report! 

Competitive Landscape:

The flexible endoscopes market is known to be fragmented owing to the large number of manufacturers functioning in it. Furthermore, key market players are focusing on acquisitions, collaborations, and product certifications to expand their product portfolios and increase sales across the globe.

Key Companies Profiled:

  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cooper Surgical
  • Endomed Systems
  • Fujifilm Corporation
  • Hoya Corporation
  • Karl Storz
  • Laborie Medical Technologies
  • Olympus Corporation
  • Richard Wolf GmbH
  • Stryker Corporation
  • Smith & Nephew, Inc.

Key Segments Covered in Flexible Endoscopes Industry Research:

By Product:

  • Upper Gastrointestinal Endoscope
    • Upper Gastrointestinal Videoscopes
    • Upper Gastrointestinal Fiberscopes
  • Colonoscopes
    • Video Colonoscopes
    • Fiber Colonoscopes
  • Bronchoscopes
    • Video Bronchoscopes
    • Fiber Bronchoscopes
  • Sigmoidoscopes
    • Video Sigmoidoscopes
    • Fiber Sigmoidoscopes
  • Laryngoscopes
    • Video Laryngoscopes
    • Fiber Laryngoscopes
  • Duodenoscopes
    • Video Duodenoscopes
    • Fiber Duodenoscopes
  • Nasopharyngoscopes
    • Video Nasopharyngoscopes
    • Fiber Nasopharyngoscopes
  • Rhinoscopes
    • Video Rhinoscopes
    • Fiber Rhinoscopes
  • Neuroendoscope
  • Cystoscopes
    • Video Cystoscopes
    • Fiber Cystoscopes
  • Laparoscopes
    • Video Laparoscopes
    • Fiber Laparoscopes
  • Other Flexible Endoscope

By Application:

  • Gastrointestinal (GI) Endoscopy
  • Laparoscopy
  • Arthroscopy
  • Obstetrics/Gynecology Endoscopy
  • Urology Endoscopy (Cystoscopy)
  • ENT Endoscopy
  • Bronchoscopy
  • Mediastinoscopy
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty clinics

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Gamma Probe Devices Market Set for Remarkable Growth: Future Market Insights Report Projects Valuation Surge to USD 244.3 Million by 2033

The global gamma probe devices market is on a trajectory of significant expansion, according to a new study by Future Market Insights (FMI). The market is anticipated to reach a valuation of USD 86.9 million by the end of 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.8%, reaching an impressive USD 244.3 million by 2033.

The study reveals a notable preference for trolley-mounted gamma probe devices, which are expected to capture a substantial market share of 38.7% in 2023. This trend underscores the versatility and efficiency of these devices, making them suitable for a wide array of applications across various medical sectors.

“We’re witnessing a dynamic shift towards trolley-mounted devices, driven by their growing demand,” says a gamma probe devices market analyst at Future Market Insights. “These devices offer unmatched versatility and efficiency, making them the preferred choice for various surgical procedures.”

One of the significant applications fueling this growth is sentinel lymph node biopsies, a routine procedure for staging melanoma and breast cancer. As the use of gamma probe devices in these procedures continues to rise, their adoption is expected to extend across other cancer types. Furthermore, the International Atomic Energy Agency (IAEA) reports a notable increase in parathyroid detection using intraoperative gamma probes, enhancing the devices’ relevance in surgical settings.

The World Cancer Research Fund International indicates that breast cancer remains the most prevalent cancer among women globally, with over 2 million new cases diagnosed each year. This alarming statistic is set to propel the growth of the gamma probe devices market in the years to come.

Innovations in the sector, such as the introduction of click-on gamma probes, represent significant advancements towards complete radio guidance integration during surgical procedures. Additionally, the DROP-IN (tethered) gamma probe concept facilitates seamless integration with robotic instruments, allowing surgeons greater autonomy and control during operations.

Despite these promising projections, the market does face potential challenges, particularly concerning the higher installation and maintenance costs associated with gamma probe devices. Nevertheless, continuous technological advancements and the development of cost-effective solutions are expected to mitigate these challenges.

FMI’s comprehensive market study, titled “Gamma Probe Devices Market,” provides valuable insights and future perspectives derived from a thorough analysis of both macro and microeconomic factors influencing market dynamics.

Key Takeaways from Gamma Probe Devices Market:

  • North America holds a significant market share with the US being subject to concentration on improvising on flexibility, throughput, and productivity. Nuclear therapies’ frequency is increasing due to remarkable investments in research on this count.
  • Europe stands second with Germany leading from the front. This could be credited to well-established players being present over here along with rising spending on healthcare.
  • The Asia-Pacific is expected to grow at a rapid pace in the gamma probe devices market in the forecast period with China dominating the scene. This could be reasoned with growing frequency of chronic ailments.

Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!

Competitive Devices:

  • Southern Scientific, in October 2021, entered into collaboration with Helgeson. The latter comes across as a producer of various detectors, equipment, and area monitors with more than 3 decades of experience in nuclear therapy.
  • KUBTEC, in May 2022, did acquire Wprobe Technology from ‘Oncovision’s firm’. The technology is looked upon as a gold standard in the radio-guided surgery and does involve a spectrum of wireless gamma probes to identify sentinel lymph node.
  • Lightpoint Medical, in February 2022, did report that Dr. Doug Adams (one of the specialists in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio)) performed the first of its kind lung procedure with SENSEI (new miniature robotic gamma probe).

What does the Report probe?

  • The research study is based on modality (handheld device, benchtop device, and trolley mounted device), by application (thyroid uptake and sentinel lymph node uptake (breast cancer, melanoma, colon cancer, NSCLC, renal cancer, and others), and by end-user (hospitals, ASCs (Ambulatory Surgical Centers), and specialty centers and clinics).
  • With growing awareness regarding advantages of gamma radiation over traditional detection methods such as X-Rays, the global gamma probe devices market is expected to stand in a good stead in the near future.

Key Companies Covered:

  • Biodex Medical Systems, Inc.
  • CAPINTEC, INC.
  • Crystal Photonics GmBH
  • Devicor Medical Products, Inc (Mammotome)
  • Dilon Technologies, Inc
  • Gamma Medical Technology
  • Intramedical Imaging
  • Intramedical Imaging
  • KUB Technologies
  • L’ACN – l’Accessorio Nucleare
  • Mammotome
  • NUCLEAR MEDSYSTEMS
  • Oncovision
  • Southern Scientific Ltd.

Key Market Segments Covered in Gamma Probe Devices Industry Research:

Modality:

  • Hand Held Device
  • Benchtop Device
  • Trolley Mounted Device

Application:

  • Thyroid Uptake
  • Sentinel Lymph Node Uptake
    • Breast Cancer
    • Melanoma
    • Colon Cancer
    • NSCLC
    • Renal Cancer
    • Others

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Centers and Clinics

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pet Diabetes Care Devices Market Poised for Remarkable Growth, Reaching USD 4.3 Billion by 2033

The global pet diabetes care devices market is experiencing significant growth, fueled by an increasing demand for advanced healthcare solutions for pets. Valued at USD 2.3 billion in 2023, the market is projected to nearly double, reaching USD 4.3 billion by 2033, with a robust Compound Annual Growth Rate (CAGR) of 6.2% throughout the forecast period.

Veterinary clinics are playing a crucial role in this expansion, acting as key facilitators in the adoption of pet diabetes care devices. Healthcare professionals and animal caretakers within these clinics are increasingly recommending and utilizing these advanced tools to enhance the management of pet health. These devices are critical for detecting, monitoring, and managing common health issues in pets, helping to prevent complications and ensuring better overall care.

The rising awareness among pet owners, combined with the proactive approach of veterinary clinics, is significantly boosting the adoption of diabetes care devices. By integrating these tools into routine care, pet owners can effectively manage their pets’ health, leading to an improved quality of life for their beloved companions.

Among the various pet diabetes care devices available, insulin pens, glucose monitoring systems, and glucose meters are designed in a range of sizes and shapes, featuring advanced functionalities for ease of use. Veterinary clinics play an instrumental role not only in informing pet owners about their pets’ conditions but also in guiding them on the benefits and usage of these devices. Additionally, they educate pet owners on the importance of providing nutritious food and regularly monitoring blood glucose levels.

With the number of pets diagnosed with diabetes on the rise, the demand for pet diabetes care devices is surging. Veterinary clinics are essential in expanding the market by offering effective tools to support pets’ health conditions, providing comprehensive training on the use of these devices, and ensuring regular monitoring at home.

As the global pet diabetes care devices market continues to grow, veterinary clinics remain at the forefront of advancing pet health management solutions, empowering pet owners to take charge of their pets’ well-being.

Key Takeaways:

  • The pet diabetes care devices market is registering a CAGR of 6.2% with a valuation of USD 4.3 billion by 2033.
  • In the historical period, the market captured a CAGR of 5.7%, with a valuation of USD 1.7 billion in 2018.
  • The United States is a prominent leader in the global market, registering a share of 27% during the forecast period.
  • China is one of the significant countries in the Asia Pacific that securing a CAGR of 8.20% by 2033.
  • During the forecast period, India is registering a CAGR of 7.50% in the global market.

Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!

How Key Players are Focus on Adding Values in the Global Market?

Key players are focusing on innovating pet diabetes care devices by adding advanced features resulting in accuracy, convenience, and ease to use. The key players are deploying small sensors in these devices to monitor pets’ health conditions, such as blood glucose levels. These devices work on a real-time basis as pet owners track the condition of their pets and provide them with healthy nutrition with a proper dietary plan.

The key players developing specially design insulin syringes to provide more accurate information than other devices. These devices provide quick results, increasing the adoption of pet healthcare to treat pets’ poor health conditions. Conversely, guiding pet owners, growing awareness, and innovating easy-to-access pet care devices improve pet health.

Recent Developments in the Global Pet Diabetes Care Devices Market are:

  • In September 2021, Zoetis Inc launched its new product VETSCAN IMAGYST. This device offers to monitor pets’ diabetes and health conditions.
  • In July 2021, Merck Animal Health launched Vetsulin to manage pets’ diabetes.
  • In 2020, IDEXX Laboratories announced its new product device IDEXX SDMA Test to identify kidney disease in cats and dogs and also the complication of diabetes.
  • In 2019, Vetoquinol announced its acquisition with Epitopix to provide vaccination for diabetes-diagnosed pets.

Other Essential Players in the Global Market are:

  • Abbot Laboratories, Inc
  • Virbac
  • Medtronic plc
  • Johnson & Johnson Services, Inc
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc
  • Novo Nordisk A/S
  • Zoetis Inc
  • Terumo Corporation
  • Boehringer Ingelheim International GmbH
  • IDEXX Laboratories
  • Johnson & Johnson Services, Inc
  • Terumo Corporation
  • Eli Lilly and Company
  • Vetoquinol S.A.

Pet Diabetes Care Devices Market by Category:

By Animal Type:

  • Cats
  • Dogs
  • Horses

By Device:

  • Insulin Delivery Devices
  • Insulin Delivery Pen
  • Insulin Syringes
  • Glucose Monitoring Devices

By End User:

  • Veterinary Clinics
  • Home Care Settings
  • Veterinary Hospitals

Region:

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Micropump Market Projected to Reach USD 12.8 Billion by 2033, Fueled by Technological Advancements and Growing Demand for Precision Drug Delivery | FMI

The global micropump market is poised for remarkable growth, with projections indicating a valuation of USD 12.8 billion by 2033, reflecting a robust compound annual growth rate (CAGR) of 18.4%. This growth trajectory underscores the dynamic expansion and burgeoning demand for micropump technology across various sectors.

A key driver behind this impressive growth is the continuous technological advancement in healthcare. As medical technology evolves rapidly, the need for sophisticated and precise drug delivery systems is escalating. Micropumps are uniquely positioned to meet this demand, providing unparalleled precision and efficiency in drug delivery applications.

Micropumps are miniature devices engineered to deliver fluids at exceptionally precise flow rates, making them indispensable in a wide array of medical and industrial applications. In the healthcare sector, their ability to offer controlled and targeted drug delivery is revolutionizing patient care, improving treatment outcomes, and minimizing side effects.

The market’s expansion is further fueled by the rising prevalence of chronic diseases and the increasing emphasis on personalized medicine. As healthcare providers strive to deliver tailored treatments, the demand for advanced drug delivery systems, such as micropumps, is expected to rise exponentially.

Beyond healthcare, the application of micropumps in industries such as biotechnology, pharmaceuticals, and environmental monitoring is also contributing to market growth. Their versatility and reliability render them essential components in various scientific and industrial processes.

As the global micropump market continues to flourish, key industry players are prioritizing innovation and strategic collaborations to maintain a competitive edge. The integration of cutting-edge technologies, including microelectromechanical systems (MEMS) and nanotechnology, is anticipated to further propel the market forward.

The projected growth of the micropump market signifies a promising future for stakeholders and investors, presenting ample opportunities for advancement and profitability. As technological advancements unfold, the role of micropumps in enhancing healthcare delivery and other critical applications is set to expand, driving the market towards unprecedented heights.

Key Takeaways from Micropump Market:

  • North America holds more than 40% of the market share. This could be attributed to higher purchasing power of the US citizens, robust support from the government regarding quality healthcare, presence of top-notch infrastructure for laboratory and clinical research, and higher adoption of various technologically advanced products.
  • The Asia-Pacific is expected to grow at the fastest rate in the micropump market due to upgradation in healthcare infrastructure all across India and China. Singapore and Malaysia are already doing well with respect to medical tourism.
  • Europe is expected to hold a significant market share with countries like Belgium, The Netherlands, and Denmark being at the forefront.

“Micropumps have evolved since the last few years through numerous techniques through advancements in electronic and digital capabilities”, says an analyst from Future Market Insights.

High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!

Competitive Micropumps:

  • Bartels Mikrotechnik GmbH, in January 2022, tabled mp6 series. They comprise mp6-Liq, mp6-gas+, and mp6-gas.
  • Sensile Medical AG (Gerresheimer’s subsidiary), September 2018, received EU certification. One of the European companies achieved CE declaration of conformity for micro-rotary pump used for treating advanced Parkinson’s disease.
  • TTP Ventus, in June 2019, launched the LT series for serving applications while demanding operational life requirements all across medical, life science, environmental, and industrial sectors.
  • Cole-Parmer India Pvt. Ltd., after successfully testing shear-sensitive and pumping live cells fluids, released the high-end micropump head series. They were named ‘Masterflex L/S Cytoflow Pump head”.
  • Biochem Fluidics, in July 2017, released Maestro ULTRA piston pump, Perialistic Pumps, Opus Rocker Valves.
  • Backtrace has its Dolomite Bio, which is known for specialization in microfluidic droplet applications that offer individual modules and microfluidic systems, reagents, and control software for applications pertaining to cell biology.

The National Institute of Biomedical Imaging and Bioengineering, in October 2020, came up with Point-of-Care Technologies Research Network for driving development of the point-of-care technologies.

Medtronic, in March 2022, tabled MiniMed 780 G systems all across India.

List Encompassing Key Players Operating in Micropump Industry:

  • LEE Ventus
  • Sensile Medical
  • Cole-Parmer India Pvt Ltd
  • IDEX
  • Dolomite Microfluidics
  • The Lee Company
  • Gardner Denver
  • Takasago Electric, Inc.
  • Halma Plc
  • Servoflo Corporation

Market Segments Covered in Micropump Industry Analysis:

By Product Type:

  • Mechanical Micropump
    • Piezoelectric Micropump
    • Peristaltic Micropump
    • Others
  • Non-mechanical Micropump

By Application:

  • Drug Delivery
  • In-vitro Diagnostics
  • Medical Devices
  • Others

By End User:

  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Automotive Brake Friction Products Market Set for Robust Growth, Projected to Reach USD 17.2 Billion by 2032 | FMI Reports

Automotive Brake Friction Products

Automotive Brake Friction Products Market

The automotive brake friction products market is on track for significant growth, with a projected CAGR of 4.8% and an expected market value of USD 17.2 billion by 2032. This expansion is primarily driven by the increasing demand for reliable, high-performance braking systems in vehicles, coupled with advancements in brake technology, rising vehicle production, and the enforcement of stringent safety regulations.

Key Drivers of Market Growth

  • Advancements in Brake Technology: Continuous innovations in braking systems are enhancing performance and safety, leading to a growing demand for high-quality brake friction products.
  • Rising Vehicle Production: The increase in global vehicle production directly correlates with a heightened need for brake friction products, as each vehicle requires a set of these components.
  • Stringent Safety Regulations: Regulatory bodies are enforcing more stringent safety standards, compelling manufacturers to adopt advanced brake technologies and materials to ensure compliance.

Comprehensive Market Insights: Full Report Overview

Market Insights and Trends

  • Replacement Rate Concerns: The replacement rate of brake friction products may be impacted by advancements in technology that extend the lifespan of these components. Manufacturers are utilizing more durable materials to meet government restrictions and adapt to varying environmental conditions.
  • Counterfeit Products Challenge: The rise in demand for auto parts has attracted counterfeiters, leading to an increase in fake brake pads and linings. Counterfeit automotive components are estimated to contribute to 20% of traffic accidents in India, causing significant financial losses and raising safety concerns.
  • Consumer Awareness Initiatives: Collaborations between the automotive industry, trade platforms, and government bodies in the U.K. are aimed at educating consumers about the risks associated with counterfeit brake friction products. Online retailers are also taking measures to combat the sale of substandard goods.

Material and Product Trends

  • Metallic Disc Materials: The use of metallic disc materials in brake friction products is expected to see a CAGR of 4.5% during the forecast period. These materials are favored for their heat resistance and effectiveness in high-performance braking applications.
  • Brake Shoes Growth: Brake shoes are anticipated to experience the fastest growth in the aftermarket segment, with a CAGR of 4.5% from 2022 to 2032. Their longer lifespan and reduced power requirements for braking compared to brake pads contribute to this trend.

Competitive Landscape:
Key players in the global automotive brake friction products market are massively aiming at expanding their manufacturing facilities, investing in research and development along with innovating new products.

The automotive brake friction products market features leading key players such as Robert Bosch, Nisshinbo Holdings Inc., Brembo S.p.A, Tenneco Inc., Federal-Mogul, Delphi, Akebono Brake Industries, ABS Friction, Bendix Spicer, Japan Brake Industrial Co., Ltd, and Toughla Brake Linings. These companies are at the forefront of innovation, focusing on advanced materials and technologies to enhance brake performance and durability. Their strategic initiatives, including research and development, mergers, and acquisitions, are pivotal in shaping the competitive landscape of the market.

More Insights into the Automotive Brake Friction Products Market:
China is predicted to account for over 30% of the global automotive brake friction products market. China is expected to create an absolute dollar opportunity by accounting for a total market share of around USD 361.2 Million by 2032. With the rise in ABS and EBD brake technologies, the demand for brake friction products is increasing continuously. The market in China is anticipated to reach a market size of USD 1.2 Billion by 2032.

Japan accounted for around 24% of the global market share in automotive brake friction products in 2021. The absolute dollar opportunity growth in Japan is projected at USD 219.1 Million during the forecast period. Japan continues to extend its offering in the Middle East and Asia for Industrial and Automotive OE in the aftermarket. Japan’s anticipated market size in the automotive brake friction product market is expected to reach USD 924.7 Million during the forecast period.

Automotive Brake Friction Products Market Segmentation:

By Disc Materials:

  • Metallic
  • Ceramic
  • Composites

By Product Type:

  • Brake Shoes
  • Break Pad
  • Brake liner
  • Disc Brake
  • Drum Brake

By Vehicle Type:

  • Passenger Vehicles
  • Commercial Vehicles

By Region:

  • North America Automotive Brake Friction Products Market
  • Latin America Automotive Brake Friction Products Market
  • Europe Automotive Brake Friction Products Market
  • South Asia Automotive Brake Friction Products Market
  • East Asia Automotive Brake Friction Products Market
  • Oceania Automotive Brake Friction Products Market
  • Middle East & Africa Automotive Brake Friction Products Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Leisure Boats Market Set to Reach USD 90,508.6 Million by 2034, Growing at a 6.1% CAGR | FMI Reports

Leisure Boats Market
Leisure Boats Market

The global leisure boat market is projected to reach USD 50,065.2 million in 2024, with an expected CAGR of 6.1% during the forecast period from 2024 to 2034. By 2034, the market value is estimated to reach approximately USD 90,508.6 million.

Among various types of leisure and recreational boats, yachts are anticipated to be in high demand through 2034. This surge is primarily driven by the increasing popularity of leisure cruising and boating, particularly in developed nations where disposable income levels are high.

While yacht sales are expected to grow at a moderate pace, companies are likely to enhance their profitability by introducing unique amenities and features. Wealthy individuals are expected to pursue high-end luxury yachts to celebrate significant life events on the water.

Comprehensive Market Insights: Full Report Overview

Key Takeaways:

  • Rising demand for electric boats will strengthen market prospects.
  • Europe’s leisure boat market will grow at a CAGR of 5.8%, reaching a value of US$ 19.6 Bn by 2032.
  • The leisure boat market in the United States will be a major contributor to market growth by generating an opportunity of US$ 26.3 Bn during the assessment period.
  • The diesel propulsion system will gain popularity and register a CAGR of 5.3% during the forecast period.

 “Integration of IoT technology, growing popularity of electric boats, and a heightened demand for used boats will likely propel the global growth of the leisure boats market over the forecast period,” – says an FMI analyst.  

Competitive Landscape 

Avon Marine, Azimut Benetti Group, Baja Marine, Bavaria Yachtbau GmbH, Bombardier Recreational Products Inc., Brunswick Corporation, Chaparral Boats Inc., Catalina Yachts, Farr Yacht Design, Ltd., Ferretti S.P.A., Fountain Powerboats, Inc., Groupe Beneteau, Sunseeker International Limited, Malibu Boats, Marine Product Corporation, MasterCraft Boat Company, Polaris Inc., and Ranger Boats among others are some of the major players in the leisure boats market profiled in the full version of the report.

Leading market players are concentrating on integrating new and advanced technologies into their products. These firms are keen on joint ventures, partnerships, and collaborations to gain a competitive advantage.

Key Segments Covered in Leisure Boats Industry Survey

Leisure Boats Market by Type:

  • New Leisure Boat
    • Motorized/Power Boats
    • Non-motorized Boats
  • Used Leisure Boat
    • Motorized/Power Boats
    • Non-motorized Boats
  • Equipment
    • Boat and Yacht Monitoring Solutions
    • IoT Sensors
    • Telematics Solutions
    • Other Equipment

Leisure Boats Market by Propulsion System:

  • Diesel
  • Gas
  • Electric / Hybrid
  • Sail Drive

Leisure Boats Market by Region:

  • North America Leisure Boats Market
  • Europe Leisure Boats Market
  • Asia Pacific Leisure Boats Market
  • Middle East & Africa Leisure Boats Market
  • Latin America Leisure Boats Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube